|
|
Volumn 28, Issue 5, 2013, Pages 602-607
|
|
Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
a
a
not available
*
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
EVEROLIMUS;
RAPAMYCIN;
ADJUVANT CHEMOTHERAPY;
ADULT;
ARTICLE;
CHILD;
COMPUTER ASSISTED DIAGNOSIS;
DRUG EFFECT;
EPENDYMOMA;
FEMALE;
FOLLOW UP;
HUMAN;
IMAGE ENHANCEMENT;
MALE;
MINIMAL RESIDUAL DISEASE;
MULTIMODALITY CANCER THERAPY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
TUBEROUS SCLEROSIS;
TUMOR RECURRENCE;
TUMOR VOLUME;
ADULT;
ANTINEOPLASTIC AGENTS;
CHEMOTHERAPY, ADJUVANT;
CHILD;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
GLIOMA, SUBEPENDYMAL;
HUMANS;
IMAGE ENHANCEMENT;
IMAGE INTERPRETATION, COMPUTER-ASSISTED;
MAGNETIC RESONANCE IMAGING;
MALE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM, RESIDUAL;
SIROLIMUS;
TUBEROUS SCLEROSIS;
TUMOR BURDEN;
YOUNG ADULT;
|
|
EID: 84880511842
PISSN: None
EISSN: 17088283
Source Type: None
DOI: 10.1177/0883073812449904 Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|
